Tag Archives: MTD

Back in October, we published this piece, outlining our thoughts on Threshold Pharmaceuticals, Inc. (NASDAQ:THLD). At the time, the company has just reported the discontinuation of its lead development program, and had collapsed on the back...

Astrazeneca PLC (NYSE:AZN) recent approval of Mavantik, lowered the regulatory risk for Relistor. AstraZeneca (AZN) received FDA approval for Movantik for the treatment of opioid-induced constipation in in patients with chronic, non-cancer pain. AstraZeneca PLC (NYSE:AZN) in last trading activity increased 0.37% to close at $67.81. Company weekly performance...

Sign Up Now For Our FREE Small Cap Newsletter